Use of vitamin D supplements during infancy in an international feeding trial
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Use of vitamin D supplements during infancy in an international feeding trial. / Lehtonen, Eveliina; Ormisson, Anne; Nucci, Anita; Cuthbertson, David; Sorkio, Susa; Hyytinen, Mila; Alahuhta, Kirsi; Berseth, Carol; Salonen, Marja; Taback, Shayne; Franciscus, Margaret; González-Frutos, Teba; Korhonen, Tuuli E; Lawson, Margaret L; Becker, Dorothy J; Krischer, Jeffrey P; Knip, Mikael; Virtanen, Suvi M; TRIGR Investigators ; Mandrup-Poulsen, Thomas.
In: Public Health Nutrition, Vol. 17, No. 4, 04.2014, p. 810-22.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Use of vitamin D supplements during infancy in an international feeding trial
AU - Lehtonen, Eveliina
AU - Ormisson, Anne
AU - Nucci, Anita
AU - Cuthbertson, David
AU - Sorkio, Susa
AU - Hyytinen, Mila
AU - Alahuhta, Kirsi
AU - Berseth, Carol
AU - Salonen, Marja
AU - Taback, Shayne
AU - Franciscus, Margaret
AU - González-Frutos, Teba
AU - Korhonen, Tuuli E
AU - Lawson, Margaret L
AU - Becker, Dorothy J
AU - Krischer, Jeffrey P
AU - Knip, Mikael
AU - Virtanen, Suvi M
AU - TRIGR Investigators
AU - Mandrup-Poulsen, Thomas
PY - 2014/4
Y1 - 2014/4
N2 - OBJECTIVE: To examine the use of vitamin D supplements during infancy among the participants in an international infant feeding trial.DESIGN: Longitudinal study.SETTING: Information about vitamin D supplementation was collected through a validated FFQ at the age of 2 weeks and monthly between the ages of 1 month and 6 months.SUBJECTS: Infants (n 2159) with a biological family member affected by type 1 diabetes and with increased human leucocyte antigen-conferred susceptibility to type 1 diabetes from twelve European countries, the USA, Canada and Australia.RESULTS: Daily use of vitamin D supplements was common during the first 6 months of life in Northern and Central Europe (>80% of the infants), with somewhat lower rates observed in Southern Europe (> 60%). In Canada, vitamin D supplementation was more common among exclusively breast-fed than other infants (e.g., 71% v. 44% at 6 months of age). Less than 2% of infants in the U.S.A. and Australia received any vitamin D supplementation. Higher gestational age, older maternal age and longer maternal education were study-wide associated with greater use of vitamin D supplements.CONCLUSIONS: Most of the infants received vitamin D supplements during the first 6 months of life in the European countries, whereas in Canada only half and in the U.S.A. and Australia very few were given supplementation.
AB - OBJECTIVE: To examine the use of vitamin D supplements during infancy among the participants in an international infant feeding trial.DESIGN: Longitudinal study.SETTING: Information about vitamin D supplementation was collected through a validated FFQ at the age of 2 weeks and monthly between the ages of 1 month and 6 months.SUBJECTS: Infants (n 2159) with a biological family member affected by type 1 diabetes and with increased human leucocyte antigen-conferred susceptibility to type 1 diabetes from twelve European countries, the USA, Canada and Australia.RESULTS: Daily use of vitamin D supplements was common during the first 6 months of life in Northern and Central Europe (>80% of the infants), with somewhat lower rates observed in Southern Europe (> 60%). In Canada, vitamin D supplementation was more common among exclusively breast-fed than other infants (e.g., 71% v. 44% at 6 months of age). Less than 2% of infants in the U.S.A. and Australia received any vitamin D supplementation. Higher gestational age, older maternal age and longer maternal education were study-wide associated with greater use of vitamin D supplements.CONCLUSIONS: Most of the infants received vitamin D supplements during the first 6 months of life in the European countries, whereas in Canada only half and in the U.S.A. and Australia very few were given supplementation.
U2 - 10.1017/S1368980013001122
DO - 10.1017/S1368980013001122
M3 - Journal article
C2 - 23795865
VL - 17
SP - 810
EP - 822
JO - Public Health Nutrition
JF - Public Health Nutrition
SN - 1368-9800
IS - 4
ER -
ID: 113810449